• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT FX VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT FX VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number EVOLUTFX-29
Device Problems Device Dislodged or Dislocated (2923); Patient Device Interaction Problem (4001)
Patient Problems Atrial Fibrillation (1729); Stroke/CVA (1770); Heart Block (4444)
Event Date 04/01/2024
Event Type  Injury  
Event Description
Medtronic received information that prior to the implant of this transcatheter bioprosthetic valve in a patient with a bicuspid aortic valve and a horizontal aorta, a pre-implant balloon aortic valvuloplasty was performed.The valve and delivery catheter system (dcs) were inserted into the patient and the valve was deployed following several attempts to advance the dcs to an appropriate depth.Following deployment, the valve dislodged to a depth of 12 mm on the non-coronary cusp and 12 mm on the left coronary cusp.Subsequently, the patient developed complete heart block, and a permanent pacemaker was implanted two days following the valve implant.It was also reported that the patient developed atrial fibrillation and right arm and hand weakness.A stroke was suspected, but unable to be confirmed via magnetic resonance imaging due to the permanent pacemaker implant.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Section d references the main component of the system.Other medical products in use during the event include: product id: d-evolutfx-2329; lot #: 0012103480; ubd: 2026-01-08; udi#: (b)(4), product id: l-evolutfx-2329; lot #: unknown; ubd: unknown; udi#: unknown.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Updated data: a3b b5 section d references the main component of the system.Other medical products in use during the event include: product id: safari; product type: guidewire.Additional codes medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Additional information was received that during the valve implant, the deployment starting point was at the bottom of the pigtail at an implant depth of 8 millimeter (mm) on the non-coronary cusp (ncc) and 2 mm on the left coronary cusp (lcc).A non-medtronic guidewire (safari) was used during the implant.New atrial fibrillation (afib) was also reported during the valve implant.Anticoagulation medication was provided for afib.Approximately 36-48 hours after the valve implant, the stroke symptoms were observed and not treatment was reported.The stroke resolved approximately 7-10 days later.The cause of the stroke was unknown.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19105284
MDR Text Key340152528
Report Number2025587-2024-02272
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00763000370701
UDI-Public00763000370701
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberEVOLUTFX-29
Device Catalogue NumberEVOLUTFX-29
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/01/2024
Initial Date FDA Received04/15/2024
Supplement Dates Manufacturer Received04/22/2024
Supplement Dates FDA Received04/26/2024
Date Device Manufactured01/29/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age82 YR
Patient SexFemale
Patient Weight67 KG
-
-